1859
About:
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Website: https://1859.ai/
Twitter/X: 18fiftynine
Top Investors: Northpond Ventures, Vertical Venture Partners, FusionX Ventures, OMX Ventures
Description:
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics. The company was founded in 2019 and is headquartered in San Diego, California.
Total Funding Amount:
$52.2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2019-01-01
Contact Email:
info(AT)eighteenfiftynine.com
Founders:
Andrew MacConnell, Devon Cayer, Ramesh Ramji, Sara Thrall Cortese
Number of Employees:
51-100
Last Funding Date:
2022-02-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai